Supplementary Materials

This PDF file includes:

  • Fig. S1. Loss of STIM1, STIM2, or FcRγ does not alter the abundance of β-hexosaminidase in BMBAs.
  • Fig. S2. Loss of both STIM1 and STIM2 inhibits both FcεRI- or IL-3R–dependent responses of BMBAs.
  • Fig. S3. IL-4 production by activated BMBAs requires intracellular and extracellular Ca2+.
  • Fig. S4. Stimulation of BMBAs with IgE/allergen, but not IL-3, elicits the Ca2+ influx.
  • Fig. S5. Generation of transgenic mice expressing a TAM-inducible improved Cre recombinase under the control of Mcpt8 promoter.
  • Fig. S6. IL-3 is dispensable for the development of IgE-CAI.
  • Fig. S7. Loss of STIM1, but not STIM2, impairs BMBA IL-4 production stimulated by IL-3 + IL-33.

[Download PDF]